Mark Beer studied at the Miami University located in Ohio graduating with a Bachelor of Science. Today, the individual is a renowned entrepreneur and philanthropist. After completing school, Beer specialized working in diagnostic, pharmaceutical, device, and biotechnology where he worked for over 25 years. During the 25 years, the individual garnered much experience in operation to thorough his career. In 2016, Beer established Renovia Inc. Shortly after starting up the business, the group underwent through the series A funding project. Among many other convergences of technology and medicine, Renovia is the most favorable and recent achievement of Mark Beer. These numerous achievements and the positions Beer held made him suitable to stand as the leader of Renovia.
The $42-million series B funding completed showed great development not just for Renovia but for Mark Beer and the entire Ohio community. Beer showed his leadership skills when he became the chief executive officer of ViaCell. The institution dealt with the development and preservation of the umbilical-cord stem cells. ViaCell later got acquired by the Perkin Elmer who had much experience in the industry. ViaCell opened doors to the public in 2005. Before getting its new possession, the organization had more than 300 employees. Mark Beer worked himself up through various leadership positions. Other posts Beer occupied include the executive vice president of global marketing. All these posts help Beer to develop much experience in diagnostic and pharmaceutical sections. The positions Beer held did not just develop his career in medicine but also gave him a chance to learn what the clients need. Therefore, the patients at Renovia have the right team of leadership in position.
Through the leadership of Mark Beer, Renovia established a product known as Leva. The commodity has a design to help women regain the health of the pelvic floor. The problem of the pelvic floor is spreading at a higher rate in the entire world. Other than Leva, the Renovia and Mark Beer are working tirelessly to invent new products to the market to fight the disease. The institution uses the Leva pelvic digital health system for women to have a quick recovery through exercise. The group uses this training product for the women to ensure that they benefit from the activities by doing them in the right manner. Other body issues appear as a result of the poor pelvic floor health and straightening. When the pelvic floor muscles are weak, you get pelvic floor disorder.
Renovia used some of its resources and funds to open up new clinical trials that began this year. The clinics will determine the effect of Leva on women who use the product when exercising as compared to those who do not use. The institution expected a turnout of over 225 women. Learn more: https://ideamensch.com/marc-beer/
Renovia’s CEO Marc Beer Raises Over $40 Million in Funding and Debt Venture
Marc Beer, the CEO of Renovia has 25 plus years of expertise in the biotechnology, diagnostics, and pharmaceutical industries. Gazette reported the beginning of October 2018 that he raised $32 million in funds and $10 million in venture debt for his new start-up company. He started the company with Ramon Iglesias and Yolanda Lorie as a medical technology entity, in 2016. Their mission is to develop diagnostic and treatment products for women diagnosed with pelvic disorders. Throughout his career, he’s started successful businesses and serves on the board of directors for companies and educational institutions.
When Beer started Renovia, he received his first round of funding from healthcare investment group, Longwood Fund. With the help of Perceptive Advisers and Ascension Ventures, he raised the second round of funding to support four of their products. In April of this year, the FDA approved a new product, Leva produced by the company. Marc told Gazette he now can improve the diagnosis and treatment for women diagnosed with the pelvic disorder. He plans to lead the development with the combination of proprietary technologies and a digital health forum.
The technologies and forum will provide educational and informative information that produces treatment options to customers. The goal is to increase understanding of the disorder that will eventually lead to reducing health care costs long term. Marc Beer explains that they designed treatments to restore pelvic health using various solutions to strengthen the muscles. He says Renovia plans to create a new generation of Leva for patients suffering from urinary contingency disorders. Pelvic floor disorder effects 250 million women and is treatable with the proper products.
Before co-finding Renovia, Marc Beer found ViaCell, a biotechnology company specializing in the development, preservation, and collection of blood stem cells. He started the business in 2000 and experienced rapid growth within seven years. By 2005, ViaCell became a public traded enterprise with 300 workers. Beer held positions with Global Marketing, Genzyme, Abbott Laboratories, Erytech Pharma, Good Start Genetics, Minerva Neurosciences, and Commonwealth of Massachusetts. His executive titles include vice president, board member director, chief executive officer, and chairman.
Marc is a Miami University graduate earning a BA in Business Science, in 1987. He has over 25 years of experience in development and commercialization in the devices, diagnostics, pharmaceutical, and biotechnology fields. While serving on the board of directors for a cancer foundation, he helped many cancer patients and their families during difficult times. Beer serves as a member of the Miami University Business Advisory Council. He served on the Graduate Studies Research and Advisory Council and the Research and Commercialization Advisory Committee at Notre Dame. Learn more: https://www1.salary.com/Marc-Beer-Salary-Bonus-Stock-Options-for-AEGERION-PHARMACEUTICALS-INC.html
Renovia Inc. has recently closed on $32 million of Series B funding to go ahead with new products treat pelvic floor disorders. The company, which was co-founded by Marc Beer in 2016, also received $10 million in venture capital as well.
The funds will be used to develop four new products addressing pelvic floor ailments, though details were not released by the company. Bizjournals.com said they will address diagnostic and therapeutic improvements that address ailments that may include urinary incontinence. Marc Beer said in a statement the company aims to improve its sensor technology to give healthcare providers the tools to incorporate better data in their treatment strategies. Beer went on to say that these improvements will “eventually” bring down healthcare costs.
The Series B included money from the Longwood Fund, which was an early investor in the Beer’s co-founded company. The Series B process was led by Perspective Advisors, based out of New York, and Missouri-based Ascension Ventures. Renovia Inc. developed the drug Leva, which was approved by the FDA back in April. The Series B funding will partly be used will be used to create a new generation of Leva, it was said in the bizjournals.com article.
Marc Beers joined two others, Ramon Iglesias and Yolanda Lorie, to create Renovia in August 2016 and was instrumental in securing the Series A funding used to develop Leva. The Longwood fund was one of those initial investors. Marc Beers co-founded Renovia Inc. after a long tenure in the medical field, has commercialized a number of products in the areas of biotechnology, pharmaceuticals, devices and diagnostics.
Among other companies he started was ViaCell, a biotechnology company that focuses on the collection, preservation, and development of umbilical cord stem cells. He led the company from inception to its growth to 300 employees to ts eventual sale to PerkinElmer in 2007. Prior to that, Marc Beers was a member of the board of directors of Erytech Pharma and held positions with Genzyme where he served most recently as the vice president of global marketing where he was instrumental in the launch of drugs addressing rare diseases across the globe. Learn more: https://renoviainc.com/leadership/
Marc Beer has extensive experience and expertise in commercialization and development in pharmaceuticals, diagnostics, devices, and biotechnology. Marc Beer cofounded Revonia alongside Yolanda Lorie, MD, and Ramon Iglesias in August 2016. The company has successfully achieved a Series A Financing with top healthcare business capital funds since its creation in 2016.
Marc Beer was appointed the Founding Chief Executive Officer of ViaCell in April 2010. ViaCell is a biotechnology firm that focuses on the activities that are involved in the collection, preservation, and development of blood stem cells of the human umbilical cord. Marc Beer led the management of ViaCell for over seven years. He helped the company to grow from its inception to become one of the rapidly growing firms with the intense commercialization of its products and services.
Marc Beer’s leadership and management of ViaCell helped it to go public in 2005, developed to offer over 300 job opportunities, and later purchased by PerkinElmer in the year 2007. Marc Beer dedicated his time and skills to ensure that he used his position as the CEO of the ViaCell to propel it from its humble beginning to attaining international standards.
Marc Beer was also a Board member of the Board of Directors of Erytech Pharma. Erytech Pharma is a publicly traded company that provides pharmaceutical products and services. He was key personnel in the board as he represented the firm in a variety of development forums. Marc Beer also held a variety of positions in Genzyme. One of the most recent post that Mr. Marc held within Genzyme was that of the Vice President of Global Marketing. Under this rank, Mr. Marc Beer was tasked with the responsibilities of the commercial launching of various products that addressed several rare diseases that affected populations around the globe.
Before joining Genzyme, Marc spent years serving Abbott Laboratories where he held various roles in sales and marketing in the diagnostic and pharmaceutical divisions. Marc was also in the Mass Life Science Board of the Massachusetts Commonwealth. He worked in the Emerging Companies Section Governing Board of the Biotechnology Industry Organization.
Marc Beer was among the founders and Founding Chairman of the Board of directors of Good Start Genetics, Inc. He was also the Chairman of the compensation committee of the organization. The Good Start Genetics, Inc. was purchased by InVatae Company just recently. Marc Beer also played some vital roles in the foundation of Minerva Neurosciences, Inc. Learn more: https://www.bizjournals.com/boston/potmsearch/detail/submission/6457372/Marc_Beer
Graeme Holm is a financial fitness expert and the founder of Infinity Group Australia. Holm started this group so that he could deal with the financial issues that affect a majority of Australians. He created this company in 2013, and so far he has helped many Australians manage their finances and secure their future. Infinity Group Australia operates by the customer-first approach. Their customer oriented approach has been proved to be working by the clients who have benefited. The organization is mainly offering debt reduction and money management services.
Why should you follow Graeme Holm?
In a world where you can barely believe anyone who comes claiming to offer support on matters of finances, why should one believe that Graeme Holm is the real deal? Holm is a first of all register as an MBA Top 100 Broker. He has also worked in the banking sector for 17 years, meaning that he is familiar with the dynamics of the financial sector.
The main reason he formed Infinity Group Australia was to address the challenge that he saw customers encountering when dealing with the banks. The banks did nothing to guide and support their customers who were in need of financial support. Usually, a bank will hand one a loan but will not do any further follow up until when they start claiming the repayment.
Graeme Holm formed Infinity Group to fill the void left by the banks. Once a customer has received a loan from the bank, Infinity Group will help in managing the loan until it is repaid in full.
Personal banker approach
To make the loan repayment simplified, Graeme Holm came up with the idea of personal bankers. These are financial experts who will monitor the financial status of the company’s clients. A personal banker will create a report of the monthly spending of the client after which they will sit down with the client to see which areas need adjustments.
Graeme Holm has formed an award-winning organization that is changing the lives of many Australians. Their clients are saving four times what they used to save in one year. This is an unprecedented change that has seen the average client of the Infinity Group Australia saving $41,000.
Graeme Holm wants to help the people secure their future early by making sure that loans are repaid in the shortest time possible. He is also helping the people realize some of the things they tend to spend a lot of money on are not necessary.
Infinity Group Australia is the solution that Australians need to secure their future. The company is a testimony of the change that guidance and education on financial management can make. People are now making better financial decisions after learning from this company. Learn more : https://angel.co/graeme-holm
Turning a hobby, something you love doing into a career is one of the most fulfilling moments in a person’s life. Over the years people have learned to turn their passion to a successful career and one such person is Clay Hutson, since his childhood Clay Hutson has always enjoyed music and after many years of trying to make things work, he was finally able to turn this passion into a career.
Currently, Clay owns a business in the entertainment industry, and he is a sound engineer who has worked his way through the ranks to emerge a success in the flooded entertainment industry. His company provides remedies for live entertainers. Before establishing his businesses, Clay worked in several organizations and was in charge of live performances as well as live tours.
After many years in the industry, Clay Hutson lost his job. He was however confident that he could make it on his own as he had perfected and gained skills over the years. Clay was confident that he could traverse any sector in the entertainment industry and this confidence contributed highly to the formation of his company.
On a normal day, Clay engages in management, supervising the stages and ensuring that the required equipment is set and the event transitions smoothly from the beginning to the end. Clay works closely with his crew to ensure that the plans turn out a success. Before he settles on other duties Clay ensures that his workers are aware of their responsibility for the day and this ensures perfection in their production.
As a businessman Clay Hutson believes that one of the attributes that have made him succeed in his work being, attention to detail. Every morning Hutson plans his tasks, and this helps him become more productive as he always prepared even in overwhelming projects.
To upcoming entrepreneurs one thing that Clay highly recommends is self-correction, ensure you check your work over and over again. This ensures that you provide quality products and services and in turn, clients get value for their money. This habit has also been a helpful marketing strategy, and this is because Clay mostly depends on word of mouth for people to know about his work.
His previous clients pass around the word to other prospect clients, and due to the quality of his work, he is able to attract new customers often.
Clay Hutson’s story is a great inspiration for aspiring business people, rising from losing his job to becoming a boss, proves that with passion and determination anything is possible. Learn more: https://www.crunchbase.com/person/clayton-hutson-1a2e
Scott Rocklage is a well respected man in the medical field. His career began when he attended the University of California, Berkeley to obtain his Bachelors in Chemistry. Scott Rocklage later attended MIT, where in 2005 he won a Nobel Peace Prize in Chemistry. He currently has over 30 years of experience in the medical field. The work he’s performed on medications, clinical trials, inventions, and publications has made his presence known all throughout the community.
A recently article on the website Medical Daily Times discusses how Scott Rocklage is paving the way for a cure to DM1. That is a genetic disorder more commonly known as Myotonic dystrophy type I. This conditions comes from RNA cells reaching toxic levels when too much protein is converted from DNA. This results in several important body organs becoming defective. As a genetic disorder, many people can be affected within a family. Having this disease can make for challenging times for a family.
In order to combat this disease, several companies have stepped up and donated a lot of money into research. Scott Rocklage recently released a press release about the lab work Matthew Disney has been performing. He states the research they have been working on for the past 12 years has produced results. Molecule medications is best the method to treat the disease. Everyone at the lab is looking forward to seeing how the tests advance. They wish to be able to fully treat any RNA disease someday.
The medical field is always full new advancements in technology. As we come to understand more, our treatment methods also progress. RNA diseases are a rare, but awful ailment in the body. The research has come a long way and has just recently began producing treatment methods. Scott Rocklage is one of those at the center of this research. His team has helped to fund the project and bought their experience along with it. At some point in the future, perhaps we will be freed of such awful diseases. Learn more: https://ideamensch.com/scott-rocklage/
As one might imagine trying to produce a world tour or even a one-off concert is not an easy feat. When an entertainer and their crew are able to pull off a successful concert or tour the audience often walks away satisfied not knowing that what they just witnessed was likely the work of hundreds of people who play a critical role in ensuring that a concert is executed without any hitches. The dreaded delays that can come during a live performance whether it is a show by a stand up comedian, a performance by a group of ballerinas or a highly anticipated show by an A-list performer due to technical difficulties are a testament to the fact that there is much more that goes into a smooth performance than the skill of the person on whom the literal spotlight is trained.
Performers are very much dependent on the stage crew who are responsible for building the sets that they execute their routines on. These crews are responsible for creating the literal landscape of the performer’s tour. For instance the Glow In The Dark tour by Kanye West saw the rapper standing on a moving platform that was covered in mist while images of outer space where projected on the wall behind him. The tour helped to define the rapper as an innovator in his genre and arguably could not have been pulled off without the assistance of a production management team. Production managers like Clayton Hutson are the hidden forces of nature who make legendary performances by the world’s favorite performers come true.
Clayton Hutson has spent years in the entertainment industry working as a production manager and a monitor engineer for various musicians and tours. Clayton Hutson has worked behind the scenes on tours for acts such as Aaron Lewis of the band Staind and R&B singer Maxwell. During his time working on the tour of Staind’s lead singer Aaron Lewis, Clay Hutson was in a role that saw him having various duties. The roles that he was responsible for executing during Aaron Lewis’ tour involved him serving as the monitor engineer and carrying out the quotidian duties that are required of a production manager and a tour manager. In addition to working behind the scenes for Aaron Lewis and Maxwell, Clay Hutson has also worked behind the scenes for other acts that include Marilyn Manson and the band OneRepublic. Learn more: https://www.linkedin.com/pub/dir/Clay/Hutson
Clayton Hutson is a production manager and sound engineer. He and his team provide services that include production management, monitor engineering, show producing, production designing, stage management, rigging, and logistics management. Some of his most recent work includes that of DiGiCo, in which he was day-to-day production tour manager and FOH monitor engineer.
He was highly intrigued with using DiGiCo on tour. He previously had used the SD8, SD7, and D5 console. The D5 was the first of its kind, and handmade for a Marilyn Manson concert. Clayton Hutson had used all of the first consoles, so being in control of Aaron Lewis’s sound had to happen.
For the Aaron Lewis tour, Hutson needed a compressed mixing system that could be stored away easily. The SD11 was only 19 inches and seemed to be the best option. It came with DiGiCo’s best sounds and functionality that Hutson relied on. He had it running perfectly within 15 minutes.
This tour was a smaller production of what Clayton Hutson typically works. He did both monitors and FOH for Ben Kitterman and Lewis’ vocals. But, the gig still had some issues. He tailored the sound to match the house and what was going on the stage. It can be difficult at times being at a casino with a smaller floor. Sometimes that sound doesn’t match what you think it will, and have to work with it.
Once the SD11 was turned on, it did not sound any different than other DiGiCo consoles. Even though it was very compact, the sound was perfect and highly reliable. The EQ reacted the same as the SD7 did. He was very impressed with the SD11.
Clayton Hutson has been working with music since he was young. He labored very hard for many years and was finally able to turn his passion into a profession. Hutson has worked with several celebrities such as Garbage, Kelly Clarkson, Pink, and Guns N’ Roses. He now has a well-known name in the industry of music for engineering, producing, and designing. For his clients, he offers easy, budget friendly, solutions. Hutson and his team give onsite execution and a one stop shop for any event needs.
Learn more: https://www.crunchbase.com/person/clayton-hutson-1a2e